These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6526141)

  • 1. Monoclonal antibodies for the control of influenza virusvaccines.
    van de Donk HJ; de Jong JC; van Olderen MF; Osterhaus AD
    Dev Biol Stand; 1984; 57():251-5. PubMed ID: 6526141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of monoclonal antibodies with ferret sera for the characterization of influenza A (H3N2) virus strains in a computer system.
    Osterhaus AD; Weijers TF; Bijlsma K; de Ronde-Verloop FM; van Asten JA; de Jong JC
    Dev Biol Stand; 1984; 57():245-50. PubMed ID: 6526140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and application of monoclonal antibodies against avian influenza virus nucleoprotein.
    Yang M; Berhane Y; Salo T; Li M; Hole K; Clavijo A
    J Virol Methods; 2008 Feb; 147(2):265-74. PubMed ID: 18006085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and optimization of a multiplex anti-influenza peptide immunoassay.
    Drummond JE; Shaw EE; Antonello JM; Green T; Page GJ; Motley CO; Wilson KA; Finnefrock AC; Liang X; Casimiro DR
    J Immunol Methods; 2008 May; 334(1-2):11-20. PubMed ID: 18329663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
    Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
    Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of monoclonal antibodies against equine influenza A/Equi-2 (H3N8) Indian isolate.
    Singh BK; Sinclair R; Gupta AK; Uppal PK; Yadav MP; Mumford JA
    Indian J Exp Biol; 1993 Sep; 31(9):774-5. PubMed ID: 8276447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology. Flu antibodies stir new hope for treatment, vaccine.
    Leslie M
    Science; 2009 Feb; 323(5918):1160. PubMed ID: 19251602
    [No Abstract]   [Full Text] [Related]  

  • 8. An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine.
    Del Giudice G; Hilbert AK; Bugarini R; Minutello A; Popova O; Toneatto D; Schoendorf I; Borkowski A; Rappuoli R; Podda A
    Vaccine; 2006 Apr; 24(16):3063-5. PubMed ID: 16464520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difficulties in standardizing the neuraminidase content of influenza vaccines.
    Gérentes L; Kessler N; Aymard M
    Dev Biol Stand; 1999; 98():189-96; discussion 197. PubMed ID: 10494973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza.
    Wu R; Chen Q; Zheng L; Chen J; Sui Z; Guan Y; Chen Z
    Arch Virol; 2009; 154(8):1203-10. PubMed ID: 19543688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of the immunoprecipitation assay to human immunogenicity of influenza vaccines.
    Brandon FB; Havlick MJ; Shillis JL
    Dev Biol Stand; 1977 Jun 1-3; 39():179-85. PubMed ID: 414949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a competitive enzyme-linked immunosorbent assay for detection of type A influenza antibodies in avian sera.
    Shafer AL; Katz JB; Eernisse KA
    Avian Dis; 1998; 42(1):28-34. PubMed ID: 9533078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
    Sawyer LA; McInnis J; Albrecht P
    Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of blocking ELISA for detection of antibodies against avian influenza virus of the H7 subtype.
    Shien JH; Fu LF; Wu JR; Cheng MC; Shieh HK; Chang PC
    J Microbiol Immunol Infect; 2008 Oct; 41(5):369-76. PubMed ID: 19122917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antigen load and storability of sensitized microtiter plates for influenza virus ELISA].
    Rosmus K; Griessmann K; Borkhardt HL
    Z Gesamte Hyg; 1985 Nov; 31(11):649-50. PubMed ID: 4090550
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antiviral effect of recombinant antibody to influenza virus HA antigen].
    Yang G; Wang Y; Zhao X; Han F; Wu S; Hou Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):337-40. PubMed ID: 12665899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination].
    Stumpa A; Tůmová B
    Tr Inst Im Pastera; 1982; 59():23-8. PubMed ID: 6764986
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method.
    Rezapkin G; Martin J; Chumakov K
    Biologicals; 2005 Mar; 33(1):29-39. PubMed ID: 15713554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of influenza vaccine formulation with a detailed analysis of the cytokine response.
    Szyszko E; Brokstad K; Cox RJ; Hovden AO; Madhun A; Haaheim LR
    Scand J Immunol; 2006 Nov; 64(5):467-75. PubMed ID: 17032238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.